Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 2
2015 2
2016 6
2017 7
2018 6
2019 1
2020 10
2021 4
2022 4
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Thyroid Gland Follicular Carcinoma"
Page 1
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Fallahi P, et al. Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26. Semin Cancer Biol. 2022. PMID: 33249201 Review.
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. ...During tumor progression, the iodide uptake capability of DTC cancer cells can be lost, making them refractory to RAI, with a negative impac …
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. ...During …
Differentiated Thyroid Cancer-Treatment: State of the Art.
Schmidbauer B, Menhart K, Hellwig D, Grosse J. Schmidbauer B, et al. Int J Mol Sci. 2017 Jun 17;18(6):1292. doi: 10.3390/ijms18061292. Int J Mol Sci. 2017. PMID: 28629126 Free PMC article. Review.
It derives from follicular thyroid cells. Generally speaking, the prognosis is excellent. ...Even metastasized tumors can be cured this way. However, in rare cases of radioiodine-refractory tumors, additional options are to be discussed. These include …
It derives from follicular thyroid cells. Generally speaking, the prognosis is excellent. ...Even metastasized tumors c …
Advanced RAI-refractory thyroid cancer: an update on treatment perspectives.
Karapanou O, Simeakis G, Vlassopoulou B, Alevizaki M, Saltiki K. Karapanou O, et al. Endocr Relat Cancer. 2022 Apr 22;29(5):R57-R66. doi: 10.1530/ERC-22-0006. Endocr Relat Cancer. 2022. PMID: 35266878 Review.
During the last decades, the knowledge on follicular cell-derived thyroid cancer molecular biology has led to the evolution of a number of novel therapies for these tumors, mainly tyrosine kinase inhibitors. Lenvantinib, sorafenib and recently cabozantinib have been …
During the last decades, the knowledge on follicular cell-derived thyroid cancer molecular biology has led to the evolution of …
Radioactive Iodine-Refractory Differentiated Thyroid Cancer in the Elderly.
Gosain R, Alexander JS, Gill A, Perez C. Gosain R, et al. Curr Oncol Rep. 2018 Sep 11;20(10):82. doi: 10.1007/s11912-018-0736-4. Curr Oncol Rep. 2018. PMID: 30206719 Review.
Most common thyroid cancers are differentiated thyroid cancers (DTCs) and have papillary, follicular, or Hurthle cell morphology. Papillary thyroid carcinoma (PTC) is the most common malignant tumor of the thyroid gland. ...
Most common thyroid cancers are differentiated thyroid cancers (DTCs) and have papillary, follicular, or Hurthle cell m …
Papillary and Follicular Thyroid Cancer in children and adolescents: Current approach and future directions.
Bauer AJ. Bauer AJ. Semin Pediatr Surg. 2020 Jun;29(3):150920. doi: 10.1016/j.sempedsurg.2020.150920. Epub 2020 May 16. Semin Pediatr Surg. 2020. PMID: 32571505 Review.
An increasing number of children are diagnosed with differentiated thyroid cancer. With an excellent prognosis for the majority of pediatric patients, the goal of therapy is to optimize outcome while reducing complications. Increased knowledge of the somatic, oncoge …
An increasing number of children are diagnosed with differentiated thyroid cancer. With an excellent prognosis for the majorit …
Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
Prasad PK, Mahajan P, Hawkins DS, Mostoufi-Moab S, Venkatramani R. Prasad PK, et al. Pediatr Blood Cancer. 2020 Jun;67(6):e28141. doi: 10.1002/pbc.28141. Epub 2020 Apr 10. Pediatr Blood Cancer. 2020. PMID: 32275118 Review.
Differentiated thyroid cancer (DTC) is the most common childhood thyroid malignancy. ...Molecular changes and potential therapeutic targets have been recently described in pediatric thyroid cancer. Pediatric oncologists are increasingly involved in the evalua …
Differentiated thyroid cancer (DTC) is the most common childhood thyroid malignancy. ...Molecular changes and potential therap …
Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
Rusinek D, Chmielik E, Krajewska J, Jarzab M, Oczko-Wojciechowska M, Czarniecka A, Jarzab B. Rusinek D, et al. Int J Mol Sci. 2017 Aug 22;18(8):1817. doi: 10.3390/ijms18081817. Int J Mol Sci. 2017. PMID: 28829399 Free PMC article. Review.
In this article, we focused on the current advantages in preoperative molecular diagnostic tests and histopathological examination including noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). We discussed the controversies regardin …
In this article, we focused on the current advantages in preoperative molecular diagnostic tests and histopathological examination including …
Efficacy and Limitations of Lenvatinib Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer: Real-World Experiences.
Masaki C, Sugino K, Saito N, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. Masaki C, et al. Thyroid. 2020 Feb;30(2):214-221. doi: 10.1089/thy.2019.0221. Epub 2020 Jan 23. Thyroid. 2020. PMID: 31854270
Tyrosine kinase inhibitors (TKIs) were recently approved for radioiodine-refractory differentiated thyroid carcinoma (RR-DTC) that is resistant to conventional therapies since they have significant potential to improve survival in patients who previously had …
Tyrosine kinase inhibitors (TKIs) were recently approved for radioiodine-refractory differentiated thyroid carcinoma (R …
Prognosis and prognostic factors of differentiated thyroid carcinoma after the appearance of metastasis refractory to radioactive iodine therapy.
Ito Y, Miyauchi A, Ito M, Yabuta T, Masuoka H, Higashiyama T, Fukushima M, Kobayashi K, Kihara M, Miya A. Ito Y, et al. Endocr J. 2014;61(8):821-4. doi: 10.1507/endocrj.ej14-0181. Epub 2014 May 27. Endocr J. 2014. PMID: 24871888 Free article.
Differentiated thyroid carcinomas (DTCs) are generally indolent, but few therapeutic strategies are available after a metastatic recurrence that is refractory to radioactive iodine (RAI) therapy. ...Here we investigated the prognosis and prognostic fac …
Differentiated thyroid carcinomas (DTCs) are generally indolent, but few therapeutic strategies are available after a metastatic recu …
Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers.
Toro-Tobon D, Morris JC, Hilger C, Peskey C, Durski JM, Ryder M. Toro-Tobon D, et al. Thyroid. 2024 Jan;34(1):70-81. doi: 10.1089/thy.2023.0456. Epub 2023 Dec 12. Thyroid. 2024. PMID: 37917101
Objective: Redifferentiation therapy (RDT) can restore radioactive iodine (RAI) uptake in differentiated thyroid cancer (DTC) cells to enable salvage (131)I therapy for previously RAI refractory (RAIR) disease. ...Results: Of the 33 patients, 57.6% had restored RAI …
Objective: Redifferentiation therapy (RDT) can restore radioactive iodine (RAI) uptake in differentiated thyroid cancer (DTC) cells t …
43 results